Bills mount for breast cancer survivors
Bills mount for breast cancer survivors

Surviving breast cancer is certainly its own reward, but a new study finds that many who do are saddled with thousands in out-of-pocket expenses for years.

Many struggle with high cost of breast cancer care
Many struggle with high cost of breast cancer care

The cost of treatment for early stage breast cancer can be devastating for many patients, but they get little guidance or help from their doctors, a new study suggests.

Low-fat diet tied to better breast cancer survival
Low-fat diet tied to better breast cancer survival

Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

Breast cancer patients may shorten Herceptin regimen: study
Breast cancer patients may shorten Herceptin regimen: study

For years, the drug Herceptin has helped women with an aggressive form of breast cancer beat the disease.

Earlier mammograms may mean less need for aggressive treatments
Earlier mammograms may mean less need for aggressive treatments

Much of the debate over when to start having mammograms has focused on lives saved, but new research suggests that early screening might also translate into smaller tumors and less aggressive breast cancer treatments.

Busting myths surrounding cancer and genetic testing
Busting myths surrounding cancer and genetic testing

While only 5 percent to 10 percent of cancers are caused by an inherited gene mutation, genetic testing may benefit people with a strong history of family cancer, an expert in genetics suggests.

Breast cancer patients may shorten Herceptin regimen: study
Breast cancer patients may shorten Herceptin regimen: study

For years, the drug Herceptin has helped women with an aggressive form of breast cancer beat the disease.

Earlier mammograms may mean less need for aggressive treatments
Earlier mammograms may mean less need for aggressive treatments

Much of the debate over when to start having mammograms has focused on lives saved, but new research suggests that early screening might also translate into smaller tumors and less aggressive breast cancer treatments.

Busting myths surrounding cancer and genetic testing
Busting myths surrounding cancer and genetic testing

While only 5 percent to 10 percent of cancers are caused by an inherited gene mutation, genetic testing may benefit people with a strong history of family cancer, an expert in genetics suggests.

Newer breast MRI may be more accurate and easier
Newer breast MRI may be more accurate and easier

A new type of MRI (magnetic resonance imaging) that doesn't use a contrast agent appears better at detecting what's really cancer and what's likely just a harmless lesion, researchers report.

Another cancer vaccine shows promise in mice
Another cancer vaccine shows promise in mice

In what researchers call a first step toward personalized vaccines for a multitude of cancers, a vaccine made from stem cells protected mice from tumors.

Extra body fat may raise breast cancer risk, no matter your weight
Extra body fat may raise breast cancer risk, no matter your weight

Older women who carry some extra body fat may face a heightened risk of breast cancer -- even if their weight is normal, a new study finds.

Screening, treatment cuts breast cancer deaths in half
Screening, treatment cuts breast cancer deaths in half

Breakthroughs in breast cancer screening and treatment have slashed the percentage of women dying from the disease, a new analysis reveals.

Just a little weight loss may cut breast cancer risk
Just a little weight loss may cut breast cancer risk

It's never too late for women to lose weight to lower their breast cancer risk, a new study suggests.

New breast cancer drug may benefit younger women, too
New breast cancer drug may benefit younger women, too

Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.

Risk of breast cancer's return can linger for decades
Risk of breast cancer's return can linger for decades

Women treated for early stage breast cancer still face a substantial risk of recurrence up to 20 years later, a large, new study shows.

Could 'AI' become a partner in breast cancer care?
Could 'AI' become a partner in breast cancer care?

Machines armed with artificial intelligence may one day help doctors better identify high-risk breast lesions that might turn into cancer, new research suggests.

Breast cancer more lethal for blacks than whites
Breast cancer more lethal for blacks than whites

Differences in insurance are a major reason why black women are more likely to die of breast cancer than white women in the United States, a new study contends.

Need cancer screening? Where you work matters
Need cancer screening? Where you work matters

Waiters, contractors and other employees of America's small businesses are more likely to miss out on cancer screening, mostly because of a lack of insurance, new research shows.

More women choose breast reconstruction after mastectomy
More women choose breast reconstruction after mastectomy

Over five years, the proportion of U.S. breast cancer patients opting for breast reconstruction after mastectomy grew by about two-thirds, a new government report shows.

Breast cancer screenings still best for early detection
Breast cancer screenings still best for early detection

Breast cancer is the second leading cause of cancer death among women in the United States, and routine screenings remain the most reliable way to detect the disease early, a breast cancer expert says.

Connect 

How breast cancer gene mutations raise risk of tumors
How breast cancer gene mutations raise risk of tumors

Scientists say they've spotted how mutations in the BRCA1 gene can trigger breast cancer.

Breast cancer's decline may have saved 322,000 lives
Breast cancer's decline may have saved 322,000 lives

New research finds the number of American women who've lost their lives to breast cancer has fallen precipitously in the past 25 years, with more than 322,000 lives saved in that time.

Verzenio approved for advanced breast cancer
Verzenio approved for advanced breast cancer

Verzenio (abemaciclib) has been approved by the U.S. Food and Drug Administration to treat women with certain advanced forms of breast cancer, the most common cancer in the United States.

US News 

Local News 

World News